Relapsed and/or Relapsed-refractory Multiple Myeloma

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Oncopeptides
OncopeptidesSweden - Stockholm
1 program
1
MelflufenPhase 1/21 trial
Active Trials
NCT01897714TerminatedEst. Mar 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OncopeptidesMelflufen

Clinical Trials (1)

NCT01897714OncopeptidesMelflufen

Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients

Start: Jul 2013Est. completion: Mar 2020
Phase 1/2Terminated

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
15m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
15m ago

Office Administrator

SystImmune
15m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
25m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
29m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
29m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)